KUOW - U K Variant Could Drive A New Surge In The U S , Experts Warn kuow.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kuow.org Daily Mail and Mail on Sunday newspapers.
“Of course, we didn’t put Democrats in the vial; we didn’t put Republicans in the vial,” University of Washington’s Dr. Larry Corey writes in a recent COVID-19 Vaccine Matters blog jointly produced by Johns Hopkins University and the UW. While development of vaccines now being distributed to combat COVID-19, the deadly disease caused by the novel coronavirus, are a “remarkable achievement” that demonstrate the power of science to save lives, mistrust and fear continue to cause nearly 40% of Americans to say they would be unlikely to get vaccinated. Larry Corey Some of that mistrust stems from before the pandemic, but unfortunate politicization of COVID-19 vaccine development is also to blame. When the current administration jumped in to claim credit for the rapid development of the vaccines, that act personalized the science behind its creation.
Cellares Adds PACT Pharma to its Early Access Partnership Program
USA - English
- Under the partnership, PACT Pharma will provide the company with insight into autologous NeoTCR manufacturing workflows to help identify product-market fit and secure early access to the technology for an undisclosed amount
- PACT Pharma is the second organization and first industry partner to join the program following Fred Hutchinson Cancer Research Center
News provided by
Share this article
SOUTH SAN FRANCISCO, Jan. 8, 2021 /PRNewswire/
Cellares Corporation, a company focused on revolutionizing cell therapy manufacturing, announced that PACT Pharma, Inc., a clinical-stage company developing transformational personalized NeoTCR-T cell therapies for the eradication of solid tumors, has joined its Early Access Partnership Program (EAPP). PACT Pharma is the second collaborator and first industry organization to join its EAPP, following Fred Hutchinson Cancer Research Center. Under the terms of